|
|
Blood, 15 December 2004, Vol. 104, No. 13, pp. 4063-4070.
Prepublished online as a Blood First Edition Paper on August 17, 2004; DOI 10.1182/blood-2004-04-1273.
Previous Article | Table of Contents | Next Article 
IMMUNOBIOLOGY
The adaptor protein SH2D1A regulates signaling through CD150 (SLAM) in B cells
Svitlana V. Mikhalap,
Larysa M. Shlapatska,
Olga V. Yurchenko,
Maria Y. Yurchenko,
Ganna G. Berdova,
Kim E. Nichols,
Edward A. Clark, and
Svetlana P. Sidorenko
From the R. E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology, National Academy of Sciences Ukraine, Signal Transduction Laboratory, Kiev, Ukraine; the University of Washington, Department of Immunology, Seattle; Children's Hospital of Philadelphia, Department of Pediatric Oncology, Philadelphia, PA.
The CD150 receptor is expressed on activated T and B lymphocytes, dendritic cells, and monocytes. A TxYxxV/I motif in the CD150 cytoplasmic tail can bind different SH2-containing molecules, including tyrosine and inositol phosphatases, Src family kinases, and adaptor molecules. To analyze CD150-initiated signal transduction pathways, we used DT40 B-cell sublines deficient in these molecules. CD150 ligation on DT40 transfectants induced the extracellular signal-regulated kinase (ERK) pathway, which required SH2-containing inositol phosphatase (SHIP) but not SH2 domain protein 1A (SH2D1A). CD150-mediated Akt phosphorylation required Syk and SH2D1A, was negatively regulated by Lyn and Btk, but was SHIP independent. Lyn directly phosphorylated Y327 in CD150, but the Akt pathway did not depend on CD150 tyrosine phosphorylation and CD150-SHP-2 association. Analysis of CD150 and SH2D1A expression in non-Hodgkin and Hodgkin lymphomas revealed stages of B-cell differentiation where these molecules are expressed alone or coexpressed. Signaling studies in Hodgkin disease cell lines showed that CD150 is linked to the ERK and Akt pathways in neoplastic B cells. Our data support the hypothesis that CD150 and SH2D1A are coexpressed during a narrow window of B-cell maturation and SH2D1A may be involved in regulation of B-cell differentiation via switching of CD150-mediated signaling pathways. (Blood. 2004;104:4063-4070)

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
C. Kamperschroer, D. M. Roberts, Y. Zhang, N.-p. Weng, and S. L. Swain
SAP Enables T Cells to Help B Cells by a Mechanism Distinct from Th Cell Programming or CD40 Ligand Regulation
J. Immunol.,
September 15, 2008;
181(6):
3994 - 4003.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Roncador, J.-F. G. Verdes-Montenegro, S. Tedoldi, J. C. Paterson, W. Klapper, E. Ballabio, L. Maestre, S. Pileri, M.-L. Hansmann, M. A. Piris, et al.
Expression of two markers of germinal center T cells (SAP and PD-1) in angioimmunoblastic T-cell lymphoma
Haematologica,
August 1, 2007;
92(8):
1059 - 1066.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Kamperschroer, J. P. Dibble, D. L. Meents, P. L. Schwartzberg, and S. L. Swain
SAP Is Required for Th Cell Function and for Immunity to Influenza
J. Immunol.,
October 15, 2006;
177(8):
5317 - 5327.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Komori, H. Furukawa, S. Mori, M. R. Ito, M. Terada, M.-C. Zhang, N. Ishii, N. Sakuma, M. Nose, and M. Ono
A Signal Adaptor SLAM-Associated Protein Regulates Spontaneous Autoimmunity and Fas-Dependent Lymphoproliferation in MRL-Faslpr Lupus Mice
J. Immunol.,
January 1, 2006;
176(1):
395 - 400.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H.-C. Chuang, J.-D. Lay, W.-C. Hsieh, H.-C. Wang, Y. Chang, S.-E. Chuang, and I.-J. Su
Epstein-Barr virus LMP1 inhibits the expression of SAP gene and upregulates Th1 cytokines in the pathogenesis of hemophagocytic syndrome
Blood,
November 1, 2005;
106(9):
3090 - 3096.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
U. Al-Alem, C. Li, N. Forey, F. Relouzat, M.-C. Fondaneche, S. V. Tavtigian, Z.-Q. Wang, S. Latour, and L. Yin
Impaired Ig class switch in mice deficient for the X-linked lymphoproliferative disease gene Sap
Blood,
September 15, 2005;
106(6):
2069 - 2075.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|